Sawtooth Asset Management »

Protagonist Therapeutics shares owned by Sawtooth Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Sawtooth Asset Management from 13F filings

Historical chart of Sawtooth Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Sawtooth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Sawtooth Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $174k 10k 16.68

More positions owned by Sawtooth Asset Management

Mirati Therapeutics
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)

View all positions for Sawtooth Asset Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics